(Q33886968)

29 July 2017

1 reference

title

Stroke prevention: anti-platelet and anti-thrombolytic therapy (English)

1 reference

29 July 2017

1 reference

Diener HC

1

1 reference

29 July 2017

publication date

1 May 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

18

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

343-355

1 reference

High-dose acetylsalicylic acid after cerebral infarction. A Swedish Cooperative Study

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. The American-Canadian Co-Operative Study group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

Thrombotic thrombocytopenic purpura after stenting and ticlopidine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

"AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

The Warfarin-Aspirin Symptomatic Intracranial Disease Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

Controversies in stroke: past and present. The Willis Lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

Low-dose aspirin and stroke. "It ain't necessarily so"

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

Controlled trial of aspirin in cerebral ischemia. Part II: surgical group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

Controlled trial of aspirin in cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

Atrial fibrillation and stroke. Revisiting the dilemmas

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

Thrombotic thrombocytopenic purpura related to ticlopidine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

Platelet-active drugs: the relationships among dose, effectiveness, and side effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

Aspirin in ischemic cerebrovascular disease. How strong is the case for a different dosing regimen?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

Vascular event rates in patients with atherosclerotic cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970196-1

7 January 2021

10.1016/S0733-8619(05)70196-1

Identifiers

DOI

1 reference

29 July 2017

1 reference